Literature DB >> 8392271

Intraoperative evaluation of prognostic factors in stage I endometrial cancer by frozen section: how reliable?

C G Zorlu1, E Kuscu, Y Ergun, T Aydogdu, O Cobanoglu, O Erdas.   

Abstract

The incidence of pelvic/paraaortic lymph node metastases is related to the grade of the tumor, the depth of myometrial invasion and the cervical involvement. These prognostic factors determine the initial surgery. Intraoperative evaluation and frozen section (FS) have been used for this purpose in order to identify patients requiring pelvic/paraaortic lymphadenectomy and adjuvant therapy, thereby eliminating routine lymphadenectomy with its complications. We used frozen section for this purpose and identified accurately 90% of patients requiring pelvic/paraaortic lymphadenectomy. The depth of myometrial invasion was accurately predicted in 90.6% and histologic grade in 91.9% of the patients; however, 60% of patients with cervical involvement were identified by FS. We recommend the use of frozen section as an inexpensive, simple and accurate way of estimating the poor prognostic factors.

Entities:  

Mesh:

Year:  1993        PMID: 8392271     DOI: 10.3109/00016349309021118

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Selected immuno-histochemical markers in curettage specimens and their correlation with final pathologic findings in endometrial cancer patients.

Authors:  Basil R Obeidat; Ismail I Matalka; Alia A Mohtaseb; Nabih S Al-Kaisi
Journal:  Pathol Oncol Res       Date:  2012-10-10       Impact factor: 3.201

2.  Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Authors:  Alper Karalok; Işın Ureyen; Yıldız Reis; Ozge Oktay; Taner Turan; Nurettin Boran; Dilek Bülbül; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-30

Review 3.  Endometrial carcinoma.

Authors:  W K Huh; J M Straughn; F J Kelly; L C Kilgore
Journal:  Curr Treat Options Oncol       Date:  2001-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.